bpc 157 production BPC-157 – No Proof Required! | Office for Science and Society How BPC-157 Accelerates Tissue Regeneration
Description
Pernicious anemiagenetic insights
Certificate of Analysis Explained
Im a participant in the Astrazeneca Phase III trial
Quick answer In circulating reference protocols a 20 mg blend vial (10 mg BPC-157 + 10 mg TB-500) is commonly reconstituted with 2 mL of bacteriostatic water yielding 5 mg/mL of each peptide and community conventions describe roughly 250500 mcg of each peptide subcutaneously per dose
Long-term considerations Most safety data on AOD 9604 comes from studies lasting 12 weeks or less
